Stay up to date on recent advances in the multidisciplinary approach to cancer.
Nurulimab/Prolgolimab Yield Superior Efficacy in Advanced Melanoma
The combination of nurulimab plus prolgolimab enhanced PFS, ORR, and DCR compared with prolgolimab monotherapy in unresectable or metastatic melanoma.
Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors
A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.
Same-Day G-CSF After Chemo Appears Safe, Efficacious in Breast Cancer
No grade 3/4 treatment-related adverse effects were observed in patients receiving efbemalenograstim alfa for breast cancer in the Guard-02 trial.
Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.
Health Care Professional Research Highlights Barriers to Clinical Trial Diversity
Radical Prostatectomy Linked to Lower GU Toxicity in Localized Prostate Cancer
Toxicity complications were assessed between single- and multiple-treatment modalities for patients with localized prostate cancer.
